SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-24-000044
Filing Date
2024-10-28
Accepted
2024-10-28 10:59:42
Documents
1
Period of Report
2024-10-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5370
  Complete submission text file 0000711377-24-000044.txt   6749
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address
Woteki Catherine E (Reporting) CIK: 0001829079 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 241399259